Rare lymphoma puzzle: scientists hunt for clues to tell two cancers apart

NCT ID NCT07313943

Recruiting now Knowledge-focused Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated May 19, 2026 · Updated 17 times

Summary

This study looks at rare lymphomas that are hard to tell apart under the microscope—some look like Hodgkin lymphoma but lack a typical marker (PAX5), while others may be a different type called ALCL. Researchers will study the genetic and protein features of these cancer cells to find better ways to diagnose them correctly. The goal is to improve treatment decisions for the 60 adult participants being recruited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN OR NON-HODGKIN LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Irccs Azienda Ospedaliero-Universitaria Di Bologna
RECRUITING

Bologna, 40138, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Universitätsklinikum Tübingen Institut für Pathologie
RECRUITING

Tübingen, 72076, Germany

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HODGKIN OR NON-HODGKIN LYMPHOMA